M. M. Skelly

1.1k total citations
22 papers, 605 citations indexed

About

M. M. Skelly is a scholar working on Surgery, Epidemiology and Pharmacology. According to data from OpenAlex, M. M. Skelly has authored 22 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in M. M. Skelly's work include Inflammatory Bowel Disease (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Salmonella and Campylobacter epidemiology (3 papers). M. M. Skelly is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Salmonella and Campylobacter epidemiology (3 papers). M. M. Skelly collaborates with scholars based in United Kingdom, Ireland and United States. M. M. Skelly's co-authors include Diarmuid P. O’Donoghue, Hugh Mulcahy, Christopher J. Hawkey, Amreen Husain, C J Hawkey, A. B. R. Thomson, Göran Långström, Angel I. Lanas, Nicholas J. Talley and Neville D. Yeomans and has published in prestigious journals such as Gastroenterology, Scientific Reports and Journal of Hepatology.

In The Last Decade

M. M. Skelly

20 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. M. Skelly United Kingdom	12	227	190	138	137	99	22	605
Miriam Barbanti Italy	14	162 0.7×	88 0.5×	77 0.6×	77 0.6×	53 0.5×	23	683
Yaşar Nazlıgül Türkiye	17	268 1.2×	46 0.2×	79 0.6×	92 0.7×	53 0.5×	52	839
Tsuguhiko Seo Japan	11	363 1.6×	190 1.0×	32 0.2×	44 0.3×	291 2.9×	26	813
Keigo Mitsui Japan	17	469 2.1×	184 1.0×	35 0.3×	61 0.4×	440 4.4×	41	1.0k
Guido Hanauer Germany	9	310 1.4×	36 0.2×	50 0.4×	38 0.3×	84 0.8×	22	602
Chia‐Yuan Liu Taiwan	15	149 0.7×	23 0.1×	99 0.7×	111 0.8×	48 0.5×	40	781
Satoshi Sobue Japan	12	74 0.3×	61 0.3×	22 0.2×	60 0.4×	51 0.5×	34	469
Christine L. E. Siezen Netherlands	16	136 0.6×	94 0.5×	22 0.2×	96 0.7×	17 0.2×	19	810
B. Kollberg Sweden	15	397 1.7×	197 1.0×	28 0.2×	45 0.3×	139 1.4×	30	821
Shoichi Kado Japan	13	104 0.5×	37 0.2×	41 0.3×	240 1.8×	44 0.4×	25	889

Countries citing papers authored by M. M. Skelly

Since Specialization

Citations

This map shows the geographic impact of M. M. Skelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. M. Skelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. M. Skelly more than expected).

Fields of papers citing papers by M. M. Skelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. M. Skelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. M. Skelly. The network helps show where M. M. Skelly may publish in the future.

Co-authorship network of co-authors of M. M. Skelly

This figure shows the co-authorship network connecting the top 25 collaborators of M. M. Skelly. A scholar is included among the top collaborators of M. M. Skelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. M. Skelly. M. M. Skelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCormick, P. Aiden, Paul Holder, Cillian De Gascun, et al.. (2025). Community prevalence of blood-borne viruses (hepatitis B and HIV) in Ireland. Irish Journal of Medical Science (1971 -). 194(2). 491–495. 1 indexed citations

McCormick, P. Aiden, Cillian De Gascun, John S. Lambert, et al.. (2024). Hepatitis C community prevalence is over-estimated: a prospective, birth cohort study. Irish Journal of Medical Science (1971 -). 193(3). 1257–1260. 1 indexed citations

Fleming, Christina, Helen Mohan, Matthew C. Kiernan, et al.. (2023). Surgical morbidity is acceptable following a one or two stage mesentery-including surgery for Crohn’s disease and comparable to mesentery-sparing surgery. 7. 1–1.

Dowling, Lisa, Philip M. Jakeman, Catherine Norton, et al.. (2021). Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission. Scientific Reports. 11(1). 19258–19258. 7 indexed citations

Skelly, M. M., et al.. (2008). Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World Journal of Gastroenterology. 14(48). 7345–7345. 23 indexed citations

Baird, Alan W., M. M. Skelly, Diarmuid P. O’Donoghue, Kim E. Barrett, & Stephen J. Keely. (2008). Bradykinin regulates human colonic ion transport in vitro. British Journal of Pharmacology. 155(4). 558–566. 15 indexed citations

Hawkey, C J, et al.. (2006). Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti‐inflammatory drugs. British Journal of Clinical Pharmacology. 61(6). 730–737. 12 indexed citations

Yeomans, Neville D., Angel I. Lanas, Nicholas J. Talley, et al.. (2005). Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Alimentary Pharmacology & Therapeutics. 22(9). 795–801. 203 indexed citations

Skelly, M. M. & Christopher J. Hawkey. (2003). Dual COX Inhibition and Upper Gastrointestinal Damage. Current Pharmaceutical Design. 9(27). 2191–2195. 11 indexed citations

10.

Hawkey, Christopher J. & M. M. Skelly. (2003). Drug-induced Gastrointestinal Disorders. Medicine. 31(3). 106–109. 1 indexed citations

11.

Skelly, M. M., et al.. (2003). Activation of cellular genes by campylobacter jejuni. Gastroenterology. 124(4). A483–A484. 1 indexed citations

12.

Skelly, M. M., Richard F. Logan, David Jenkins, Yashwant R. Mahida, & Christopher J. Hawkey. (2002). Toxicity of Mycophenolate Mofetil in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 8(2). 93–97. 34 indexed citations

13.

Hawkey, Christopher J. & M. M. Skelly. (2002). Gastrointestinal Safety of Selective COX-2 Inhibitors. Current Pharmaceutical Design. 8(12). 1077–1089. 26 indexed citations

14.

Logan, Richard F. & M. M. Skelly. (2002). Maintenance infliximab delayed loss of response in active Crohn disease. ACP Journal Club. 137(3). 92–92. 1 indexed citations

15.

Logan, Richard F. & M. M. Skelly. (2000). Smoking and hepato-biliary disease. European Journal of Gastroenterology & Hepatology. 12(8). 863–867. 5 indexed citations

16.

Taylor, Cormac T., D. C. Winter, M. M. Skelly, et al.. (1999). Berberine inhibits ion transport in human colonic epithelia. European Journal of Pharmacology. 368(1). 111–118. 53 indexed citations

17.

Skelly, M. M., et al.. (1999). Liver Absecesses with Bilioportal Fistula. Journal of Hepatology. 31(2). 365–365. 3 indexed citations

18.

Skelly, M. M., M. J. Duffy, Hugh Mulcahy, et al.. (1997). Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.. PubMed. 3(10). 1837–40. 48 indexed citations

19.

Mulherin, D., M. M. Skelly, Denis M. McCarthy, et al.. (1996). The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures.. PubMed. 23(2). 237–40. 13 indexed citations

20.

Mulcahy, Hugh, M. M. Skelly, Amreen Husain, & Diarmuid P. O’Donoghue. (1996). Long-term outcome following curative surgery for malignant large bowel obstruction. British journal of surgery. 83(1). 46–50. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact